Ignite Creation Date:
2025-12-25 @ 1:39 AM
Ignite Modification Date:
2026-03-04 @ 3:00 PM
Study NCT ID:
NCT02632994
Status:
AVAILABLE
Last Update Posted:
2025-09-29
First Post:
2015-12-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Master Rollover Protocol for Continued Safety Assessment of Study Drug
Sponsor:
Eli Lilly and Company
Organization:
Study Overview
Official Title:
Master Rollover Protocol for Continued Safety Assessment of Study Drug
Status:
AVAILABLE
Status Verified Date:
2025-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is for patients who have participated in a previous study and who continue to receive benefit to have continued access to study drug and/or treatment.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| I8I-MC-JYAA | OTHER | Eli Lilly and Company | View |